AzTrials
AzTrials

Nutritional SupplementationEarly Phase 1NCT06714331

Caffeine and Sodium Bicarbonate Supplementation Effects on Resistance Training Performance

A Early Phase 1 study testing Supplements in people with Nutritional Supplementation and Resistance Training, run by Memorial University of Newfoundland at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research aims to explore the effects of two supplements, caffeine and sodium bicarbonate, on acute (short-term) resistance training performance. The present study aims to assess the effects of caffeine and sodium bicarbonate supplementation on the number of repetitions, muscle activation, speed of movement, and… Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
What is being tested?
Supplements
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
12 participants
Where
1 siteCanada
Study dates
1 Aug 2024to 5 May 2025
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • apparently healthy, physically active males and females between 18-40 years of age with regular (minimum three times a week) resistance training experience for the last 6 months and regular caffeine intake (at least once a day).

Who cannot join

  • recent musculoskeletal or musculotendinous injuries

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Memorial University of Newfoundland

    St. John's, Newfoundland and Labrador, A1C 5S7

Other trials in Canada

About this study

Official title: The Effect of Acute Caffeine and Sodium Bicarbonate Supplementation on Upper and Lower Submaximal Resistance Training Performance

This research aims to explore the effects of two supplements, caffeine and sodium bicarbonate, on acute (short-term) resistance training performance. The present study aims to assess the effects of caffeine and sodium bicarbonate supplementation on the number of repetitions, muscle activation, speed of movement, and fatigue during resistance training.

Read the detailed description

The study will employ a randomized, double-blind, placebo-controlled, cross-over study design that examines the effect of caffeine and sodium bicarbonate on knee extension and bench press performance. Parameters include peak isoinertial force (1 repetition maximum: 1RM), rate of force development, movement velocity, number of repetitions to failure with a 10 repetition maximum (10RM) load, and electromyography (EMG) activity. The participants will complete three separate visits to the laboratory (1. placebo, 2. caffeine, and 3. sodium bicarbonate ingestion). With respect to the first visit, participants will sign a consent form and complete a health history questionnaire. Their respective anthropometric measurements will be taken, including height, weight, body mass index (BMI). Participants will then be introduced to the rate of perceived exertion scale for use during the trials. Blood lactate (Lactate Pro, Arkray, Kyoto, Japan) levels will be collected and analyzed from the index finger of the tested arm. Researchers will establish the 1RM for the bench press (upper-body) and knee extension (lower-body) exercises. The participants will complete a warm-up set of 8-10 repetitions at 50% of their body mass, followed by a 60-second rest period. The participants will then complete a second warm-up set of 3-5 repetitions with a 5-10 kg increase from the initial set, followed by another 60-second rest interval. the participants will then complete 2-3 repetitions with an additional 5-10 kg increase, followed by a rest for an additional 120 seconds. Each subsequent one-repetition attempt increased an additional 5-10 kg, followed by a 120-second rest period. The final attempt will be determined by repeating the steps illustrated above until the participants can no longer complete a single unassisted repetition with additional weight. This value will then be illustrated as the participant's 1RM and will be utilized to calculate exercise intensity for the two subsequent supplementation trials.

All testing will be performed within the laboratory. Participants are instructed to meet the following conditions 24-h before each experimental trial: (i) to avoid vigorous exercise, (ii) to adopt a similar diet and drink intake, (iii) to refrain from the consumption of alcohol, caffeine, and other stimulants.

Measures

For the knee extension measures, EMG activity will be collected from the mid-belly (midway between the anterior superior iliac spine to the superior edge of the patella) of the vastus lateralis and biceps femoris (midway between the gluteal fold and the popliteal space) of the non-dominant leg. Before participants perform the bench press, surface EMG recording electrodes will be placed approximately 3 cm apart over the proximal, lateral segment of the biceps brachii and over the lateral head of the triceps brachii. The distance of the biceps brachii electrodes from the acromion process and the distance of the triceps electrodes from the biceps electrodes will be recorded to ensure accurate replacement for subsequent tests. A thorough skin preparation for all electrodes will include shaving and removal of dead epithelial cells with abrasive pad around the designated areas, followed by cleansing with an isopropyl alcohol swab. EMG will be collected using a Biopac (Biopac Systems Inc.) data acquisition system at a sample rate of 2,000 Hz [impedance = 2 MΩ, common mode rejection ratio >110 dB min (50/60 Hz), noise >5 μV]. A bandpass filter (10-500 Hz) will be applied prior to digital conversion.

The root mean square (RMS) EMG will be monitored throughout the range of movements for both the bench press and knee extension. The mean RMS EMG will be normalized to the highest pre-test value and reported as a percentage.

A linear position transducer (Chronojump; Boscosystem, Barcelona, Spain) will be attached to the barbell to measure the excursion of the movement, time, and velocity. This device has been previously validated for velocity and power measurements.

Blood lactate levels will be measured with StatStrip Xpress Lactate (SSX) (Nova Biomedical, Waltham, Massachusetts, USA) prior to, during, and after the bench press and knee extension exercises to determine blood-lactate levels of the participants.

The participant's heart rate and rating of perceived exertion will be collected immediately after the completion of each set.

Intervention

During the subsequent three visits, participants will consume the placebo (dextrose), caffeine or sodium bicarbonate. A one week washout period will be allocated between visits. The same quantity will be used during both testing trials to ensure that the supplement is the only variable. The participants will spend 1 hour in a seated resting position after consuming the placebo or supplement. Participants will then utilize the same warm-up as the first visit, 8-10 repetitions at 50% of their body mass.

Testing Procedure

Using a 10RM load, participants will be instructed to complete as many repetitions as possible for each set (6 sets for each exercise) until they can no longer complete a repetition without assistance. Researchers will then record the number of repetitions participants complete during each set. The participant will then undergo a 60-second rest period between each set. After the participant completes the first exercise (e.g., six bench press or knee extension sets), they will undergo a 120-second rest period before beginning the same procedure on the next exercise (i.e., bench press or isoinertial knee extension resistance device). The order of bench press and knee extension exercises will be randomized.

Being tested
Supplements
Keywords
caffeine, sodium bicarbonate, strength, fatigue, resistance training
Medical subject headings
Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SupplementsDietary supplement

    Supplements provided to subjects 2 hours prior to testing and drank at 2 hours, 90 minutes and 45 minutes before testing.

Study groups in NCT06714331
Study groupRoleWhat they receive
CaffeineExperimentalCaffeine supplement is consumed at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of a caffeine and water solution at each time for a total consumed volume of 900mL . Caffeine concentration - 3mg/kg or 0.003g/kg Each solution has MiO Liquid Water Enhancer to mask the taste.
Receives: Dietary Supplement: Supplements
Sodium bicarbonateExperimentalSodium bicarbonate supplement is consumed at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of sodium bicarbonate solution at each time for a total consumed volume of 900mL. Sodium bicarbonate concentration - 0.3g/kg (Arm and Hammer brand) Each solution has MiO Liquid Water Enhancer to mask the taste.
Receives: Dietary Supplement: Supplements
ControlSham comparatorControl solution is MiO + 300mL water at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of control solution at each time for a total consumed volume of 900mL.
Receives: Dietary Supplement: Supplements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bench press repetitions to failure

    During familiarization participants 12 repetition maximum was calculated. After drinking supplement or control participants perform 6 sets of 12 repetition bench press maximum repetitions to failure.

    Outcome measure is the number of repetitions completed in each set of the 6 sets.

    Measured: 45 minutes after last consumption of supplement or control drink solution.Order of bench press vs. knee extension is randomized.

  2. Knee extensions repetitions to failure

    During familiarization participants 12 repetition maximum was calculated. After drinking supplement or control participants perform 6 sets of 12 knee extension maximum repetitions to failure.

    Outcome measure is the number of repetitions completed in each of the 6 sets.

    Measured: 45 minutes after last consumption of supplement or control drink solution. Order of bench press vs. knee extension is randomized.

Secondary outcomes (4)
  1. Blood lactate

    Blood lactate obtained from index finger. Outcome measure is the millimoles of blood lactate at each testing time.

    Measured: Pre- (1 minute prior to ingestion of supplement solution) and post-tests (1 minute after each bout of bench press and knee extensions to failure). Each measure should take 5 seconds.

  2. Heart rate

    Heart rate detected by heart rate monitor instantaneously Outcome measure is the heart rate reported in beats per minute at each testing time.

    Measured: Heart rate (instantaneous feedback by monitor) will be recorded 10 seconds after every bench press and knee extension set in each condition/session (caffeine, sodium bicarbonate and control sessions).

  3. Rating of perceived exertion

    Adapted Borg scale with scale from 1-10. Reporting should take 2 seconds upon each request by the investigator.

    Outcome measure is the participant's reported scale number at each testing time.

    Measured: Recorded 20 seconds (response time = 2 seconds) after every bench press and knee extension set in each condition/session (caffeine, sodium bicarbonate and control sessions).

  4. Electromyography (EMG) root mean square (Mean amplitude)

    Surface EMG electrodes will be used to monitor muscle activation with every set of resistance training. The mean amplitude of the root mean square (RMS) of the EMG will be measured over the duration of each repetition. Filtering (band pass 5-500 Hz) and amplification (1000X) of the signal will be processed through a BioPac AcqKnowledge software system.

    Measured: During every repetition to failure sets. Each set will take a maximum of 30 seconds. With fatigue from the repetitive 6 sets, the exercise and monitoring time will decrease.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2024
  2. Study start1 Aug 2024
  3. Primary completion5 Apr 2025
  4. Study completion5 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
randomized, double-blind, placebo-controlled, cross-over study design with 1 intervention (supplements) with 3 arms (caffeine, sodium bicarbonate, control placebo).
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06714331
Sponsor's protocol ID
20241611
Status last verified
Feb 2026
First submitted
1 Aug 2024
Last updated
17 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will be available upon request to the individual. Anonymized data of the group will be available as supplementary material upon submission to a journal.

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Supplements in people with Nutritional Supplementation and Resistance Training, run by Memorial University of Newfoundland at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bench press repetitions to failure (time frame: 45 minutes after last consumption of supplement or control drink solution.Order of bench press vs. knee extension is randomized.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in